Orgenesis board approves 1-for-10 reverse stock split

Written by Emily J. Thompson, Senior Investment Analyst

ORGS%

Updated: Sep 23 2024

0mins

Reverse Stock Split Announcement: Orgenesis has approved a 1-for-10 reverse stock split effective September 24, 2024, to comply with Nasdaq's minimum bid price requirement of $1.00 per share.
Trading Continuation: The company's common stock will continue trading on The Nasdaq Capital Market under the symbol "ORGS" on a split-adjusted basis starting September 25, 2024.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Orgenesis board approves 1-for-10 reverse stock split

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Top Growth Stocks to Buy Now: Nvidia, Amazon, Dutch Bros

Bitcoin's Market Cap Exceeds $1.9 Trillion, Potential to Reach $1.2 Million

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch